Doç. Dr. Özlem MERMUT

1. Exceptional Long-term Survival in BRAF V600E-mutant Anaplastic Pleomorphic Xanthoastrocytoma: A Case Report with 12-year Disease-free Follow-up

Solmaz B., MERMUT Ö., Rakıcı İ. T., LEBLEBİCİ C.

Acta Haematologica Oncologica Turcica , cilt.59, sa.1, ss.70-73, 2026 (Scopus, TRDizin)

2. Assessment of radiotherapy effect and toxicity using tissue-associated DNA methylation markers in cell-free DNA: a study on prostate cancer

BAHTİYAR N., MERMUT Ö., FIRTINA S., ÖZAYDIN A., Suleymanova A., Isikgil B., et al.

Radiation and Environmental Biophysics , cilt.65, sa.1, ss.461-472, 2026 (SCI-Expanded, Scopus)

3. Integral Dose and Dosimetric Comparison of 3D-CRT, IMRT and VMAT Radiotherapy Techniques for Prostate Cancer

MERMUT Ö., Özsoy Ata A., Inanc B., Tuncay E., Ökten B.

Iranian Journal of Medical Physics , cilt.22, sa.6, ss.405-410, 2025 (Scopus)

4. Synchronous/Metachronous Bilateral Breast Cancer: a Long-Term Follow-up Single-Center Experience

MERMUT Ö., YALÇIN B., GÜRSU R. U., Trabulus D. C., Dal F., Talu E. C. K., et al.

Indian Journal of Surgery , cilt.86, sa.4, ss.760-767, 2024 (SCI-Expanded, Scopus)

5. Predictors of recurrence in breast cancer patients with pathological partial response

Trabulus F. D. C., Nazli M. A., ARSLAN E., MERMUT Ö., Dal F., Akce B., et al.

Revista da Associacao Medica Brasileira , cilt.70, sa.3, 2024 (SCI-Expanded, Scopus)

6. The immunohistochemical Galectin-3 expression in tumor and cancer-associated fibroblasts in invasive ductal carcinomas of breast and their relationship with clinicopathological parameters

ÇAKIR KIYMAZ Y., Talu C., Trabulus D., MERMUT Ö.

Indian Journal of Pathology and Microbiology , cilt.66, sa.3, ss.456-464, 2023 (SCI-Expanded, Scopus)

7. Diagnostic Conflict in Occult Breast Cancers and Clinical Results of a Tertiary Center: A Cross-sectional Study

Dal F., Ökmen H., Ulusan K., Havare S. B., MERMUT Ö., Nazlı M. A., et al.

Indian Journal of Surgery , cilt.85, sa.3, ss.522-530, 2023 (SCI-Expanded, Scopus)

8. The roles of 68Ga-PSMA PET/CT and 18F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings

ARSLAN E., Ergül N., BEYHAN E., Erol Fenercioglu Ö., Sahin R., Cin M., et al.

Nuclear Medicine Communications , cilt.44, sa.4, ss.284-290, 2023 (SCI-Expanded, Scopus)

9. Radiomics of locally advanced rectal cancer: machine learning-based prediction of response to neoadjuvant chemoradiotherapy using pre-treatment sagittal T2-weighted MRI

YARDIMCI A. H., Kocak B., Sel I., Bulut H., Bektas C. T., Cin M., et al.

Japanese Journal of Radiology , cilt.41, sa.1, ss.71-82, 2023 (SCI-Expanded, Scopus)

10. Comparison of Treatment Results and Prognostic Factors of Elderly and Young Patients Receiving Neoadjuvant Chemoradiotherapy in Rectal Cancer

Inanc B., MERMUT Ö.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.32, sa.1, ss.57-64, 2022 (SCI-Expanded, Scopus, TRDizin)

11. The Expression of Galectin-3 in Tumor and Cancer-Associated Fibroblasts in Invasive Micropapillary Breast Carcinomas: Relationship with Clinicopathologic Parameters

Çakır Y., Kelten Talu C., MERMUT Ö., Can Trabulus D., ARSLAN E.

European Journal of Breast Health , cilt.17, sa.4, ss.341-351, 2021 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

12. Quantitative and dosimetric analysis for treating synchronous bilateral breast cancer using two radiotherapy planning techniques

MERMUT Ö., Ata A. O., Trabulus D. C.

Polish Journal of Medical Physics and Engineering , cilt.27, sa.3, ss.201-206, 2021 (ESCI, Scopus)

13. Alternative volumetric PET pjmirometers for evaluation of breast cancer cases with 18F-FDG PET/CT imaging: Metabolic tumour volume and total lesion glycolysis

ARSLAN E., Can Trabulus D., MERMUT Ö., Şavlı T. C., Çermik T. F.

Journal of Medical Imaging and Radiation Oncology , cilt.65, sa.1, ss.38-45, 2021 (SCI-Expanded, Scopus)

14. Prognostic value of C-reactive protein-to-albumin ratio and inflammatory markers in esophageal cancer patients treated with chemoradiotherapy

Inanc B., MERMUT Ö.

Journal of Clinical Medicine of Kazakhstan , cilt.18, sa.2, ss.61-65, 2021 (Scopus)

15. The Effect of Indicators of Systemic Inflammatory Response on Survival in Glioblastoma Multiforme

MERMUT Ö., INANC B.

Turkish Neurosurgery , cilt.30, sa.5, ss.658-665, 2020 (SCI-Expanded, Scopus, TRDizin)

16. Survival and treatment outcomes in patients with extracranial oligometastatic breast cancer: Single-center experience

MERMUT Ö., Trabulus D. C., ARSLAN E., Nazli M. A.

Turk Onkoloji Dergisi , cilt.35, sa.3, ss.327-333, 2020 (ESCI, Scopus, TRDizin)

17. Prognostic factors and survival of elderly women with breast cancer aged ≥70 years Yetmiş yaş ve üzeri meme kanserli yaşli kadinlarda prognostik faktörler ve sağkalim

MERMUT Ö., İnanç B.

Turk Geriatri Dergisi , cilt.22, sa.4, ss.426-433, 2019 (SCI-Expanded, SSCI, Scopus, TRDizin)

Doç. Dr. Özlem MERMUT

Yayınlar & Eserler

1. Exceptional Long-term Survival in BRAF V600E-mutant Anaplastic Pleomorphic Xanthoastrocytoma: A Case Report with 12-year Disease-free Follow-up

2. Assessment of radiotherapy effect and toxicity using tissue-associated DNA methylation markers in cell-free DNA: a study on prostate cancer

3. Integral Dose and Dosimetric Comparison of 3D-CRT, IMRT and VMAT Radiotherapy Techniques for Prostate Cancer

4. Synchronous/Metachronous Bilateral Breast Cancer: a Long-Term Follow-up Single-Center Experience

5. Predictors of recurrence in breast cancer patients with pathological partial response

6. The immunohistochemical Galectin-3 expression in tumor and cancer-associated fibroblasts in invasive ductal carcinomas of breast and their relationship with clinicopathological parameters

7. Diagnostic Conflict in Occult Breast Cancers and Clinical Results of a Tertiary Center: A Cross-sectional Study

8. The roles of 68Ga-PSMA PET/CT and 18F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings

9. Radiomics of locally advanced rectal cancer: machine learning-based prediction of response to neoadjuvant chemoradiotherapy using pre-treatment sagittal T2-weighted MRI

10. Comparison of Treatment Results and Prognostic Factors of Elderly and Young Patients Receiving Neoadjuvant Chemoradiotherapy in Rectal Cancer

11. The Expression of Galectin-3 in Tumor and Cancer-Associated Fibroblasts in Invasive Micropapillary Breast Carcinomas: Relationship with Clinicopathologic Parameters

12. Quantitative and dosimetric analysis for treating synchronous bilateral breast cancer using two radiotherapy planning techniques

13. Alternative volumetric PET pjmirometers for evaluation of breast cancer cases with 18F-FDG PET/CT imaging: Metabolic tumour volume and total lesion glycolysis

14. Prognostic value of C-reactive protein-to-albumin ratio and inflammatory markers in esophageal cancer patients treated with chemoradiotherapy

15. The Effect of Indicators of Systemic Inflammatory Response on Survival in Glioblastoma Multiforme

16. Survival and treatment outcomes in patients with extracranial oligometastatic breast cancer: Single-center experience

17. Prognostic factors and survival of elderly women with breast cancer aged ≥70 years Yetmiş yaş ve üzeri meme kanserli yaşli kadinlarda prognostik faktörler ve sağkalim

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Açık Erişim